GE Medical Systems has received Food and Drug Administration 510(k) clearance for its Platinum line of Windows NT-based diagnostic and clinical review workstations. The workstations, which will also employ Java technology, are scheduled for a
GE Medical Systems has received Food and Drug Administration 510(k) clearance for its Platinum line of Windows NT-based diagnostic and clinical review workstations. The workstations, which will also employ Java technology, are scheduled for a fourth-quarter commercial release, according to the Milwaukee company.
The regulatory approval marks an important milestone for GE in its quest for PACS market dominance. With customer interest centering on systems based on the Microsoft platform, many market watchers consider a lack of an NT-based offering a liability. GE's PACS is currently based on the Macintosh platform.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.